 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - CRISPR Therapeutics AG (CRSP)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-09-01 Sale | 2020-09-03 9:21 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 60,000 | $92.51 | $5,550,644 | 0 (Indirect) | View |
| 2020-09-09 Sale | 2020-09-11 9:49 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 22,845 | $85.36 | $1,949,996 | 531,345 (Indirect Direct) | View |
| 2020-09-14 Sale | 2020-09-16 8:00 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,155 | $84.89 | $98,045 | 530,190 (Indirect Direct) | View |
| 2020-09-16 Sale | 2020-09-18 4:30 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 8,965 | $86.98 | $779,778 | 521,225 (Indirect Direct) | View |
| 2020-09-18 Sale | 2020-09-22 8:10 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 3,035 | $86.87 | $263,636 | 518,190 (Indirect Direct) | View |
| 2020-10-08 Sale | 2020-10-13 4:44 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 25,000 | $100 | $2,500,000 | 648,007 (Direct) | View |
| 2020-11-30 Sale | 2020-12-02 4:26 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 100,000 | $125 | $12,500,000 | 648,007 (Direct) | View |
| 2020-12-07 Sale | 2020-12-09 7:54 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 171,004 | $154.53 | $26,424,505 | 347,186 (Indirect Direct) | View |
| 2020-12-10 Sale | 2020-12-11 4:05 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $142.29 | $2,845,782 | 169,189 (Direct) | View |
| 2020-12-10 Sale | 2020-12-14 7:11 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 33,000 | $143.35 | $4,730,448 | 314,186 (Indirect Direct) | View |
| 2020-12-10 Sale(A) | 2020-12-17 7:14 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 33,000 | $143.35 | $4,730,448 | 7,648 (Indirect Direct) | View |
| 2020-12-16 Sale | 2020-12-18 7:12 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $148.95 | $2,234,265 | 339,834 (Indirect Direct) | View |
| 2020-12-21 Sale | 2020-12-22 4:55 pm | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 23,551 | $149.23 | $3,514,610 | 33,964 (Direct) | View |
| 2021-01-19 Sale | 2021-01-20 6:05 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 27,500 | $204.94 | $5,635,944 | 22,431 (Direct) | View |
| 2021-01-15 Sale | 2021-01-20 6:07 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $215.2 | $5,379,940 | 20,000 (Direct) | View |
| 2021-01-15 Sale | 2021-01-20 6:11 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $213.67 | $4,273,311 | 182,989 (Direct) | View |
| 2021-02-19 Sale | 2021-02-23 4:40 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 171,003 | $149.11 | $25,497,840 | 168,831 (Indirect Direct) | View |
| 2021-03-22 Sale | 2021-03-24 6:00 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,374 | $132.37 | $4,020,667 | 30,375 (Indirect Direct) | View |
| 2021-03-23 Sale | 2021-03-25 5:39 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 100,000 | $128.05 | $12,805,240 | 1,050 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,000 | $14 | 30,000 (Indirect) | View |
| 2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $13.62 | 45,000 (Indirect) | View |
| 2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $59.31 | 60,000 (Indirect) | View |
| 2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A 2026-10-18 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,000 | $0 | 30,000 (Indirect) | View |
| 2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A 2027-05-31 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $0 | 15,000 (Indirect) | View |
| 2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A 2028-06-15 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $0 | 15,000 (Indirect) | View |
| 2020-09-09 Other | 2020-09-11 9:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 164,162 | $0 | 2,074,817 (Indirect) | View |
| 2020-09-09 Other | 2020-09-11 9:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 974 | $0 | 12,303 (Indirect) | View |
| 2020-09-09 Other | 2020-09-11 9:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 42,272 | $0 | 42,272 (Indirect) | View |
| 2020-09-09 Other | 2020-09-11 9:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 42,272 | $0 | 0 (Indirect) | View |
| 2020-09-09 Other | 2020-09-11 9:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 7,391 | $0 | 7,391 (Direct) | View |
| 2020-09-22 Other | 2020-09-24 6:09 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 328,324 | $0 | 1,746,493 (Indirect) | View |
| 2020-09-22 Other | 2020-09-24 6:09 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 84,544 | $0 | 84,544 (Indirect) | View |
| 2020-09-22 Other | 2020-09-24 6:09 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 84,544 | $0 | 0 (Indirect) | View |
| 2020-09-22 Other | 2020-09-24 6:09 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,948 | $0 | 10,355 (Indirect) | View |
| 2020-09-22 Other | 2020-09-24 6:09 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 14,780 | $0 | 22,171 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:32 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 16,666 | $0 | 16,666 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:34 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 11,666 | $0 | 11,666 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:38 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,666 | $0 | 16,666 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:45 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 47,333 | $0 | 47,333 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:48 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 11,666 | $0 | 11,666 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 4:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 22,238 | $14.43 | 670,245 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 4:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 2,762 | $14.43 | 650,769 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 4:44 pm | N/A 2027-06-15 | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 22,238 | $0 | 193,077 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 4:44 pm | N/A 2027-06-15 | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 2,762 | $0 | 190,315 (Direct) | View |
| 2020-10-29 Other | 2020-11-02 5:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 410,405 | $0 | 1,336,088 (Indirect) | View |
| 2020-10-29 Other | 2020-11-02 5:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 105,681 | $0 | 105,681 (Indirect) | View |
| 2020-10-29 Other | 2020-11-02 5:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 105,681 | $0 | 0 (Indirect) | View |
| 2020-10-29 Other | 2020-11-02 5:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 2,433 | $0 | 7,922 (Indirect) | View |
| 2020-10-29 Other | 2020-11-02 5:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 18,477 | $0 | 40,648 (Direct) | View |
| 2020-11-30 Exercise | 2020-12-02 4:26 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 50,000 | $14 | 698,007 (Direct) | View |
| 2020-11-30 Exercise | 2020-12-02 4:26 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 50,000 | $14.43 | 698,007 (Direct) | View |
| 2020-11-30 Exercise | 2020-12-02 4:26 pm | N/A 2026-10-18 | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 50,000 | $0 | 61,893 (Direct) | View |
| 2020-11-30 Exercise | 2020-12-02 4:26 pm | N/A 2027-06-15 | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 50,000 | $0 | 140,315 (Direct) | View |
| 2020-12-01 Tax Withholding | 2020-12-03 4:32 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 779 | $129.58 | 169,189 (Direct) | View |
| 2020-12-09 Exercise | 2020-12-10 4:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 22,026 | $13.62 | 22,415 (Direct) | View |
| 2020-12-09 Exercise | 2020-12-10 4:35 pm | N/A 2027-05-31 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 22,026 | $0 | 100,974 (Direct) | View |
| 2020-12-10 Exercise | 2020-12-11 4:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $1.81 | 189,189 (Direct) | View |
| 2020-12-10 Exercise | 2020-12-11 4:05 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $0 | 142,783 (Direct) | View |
| 2020-12-21 Exercise | 2020-12-22 4:55 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 23,551 | $16.9 | 57,515 (Direct) | View |
| 2020-12-21 Exercise | 2020-12-22 4:55 pm | N/A 2027-08-01 | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 23,551 | $0 | 236,449 (Direct) | View |
| 2020-12-29 Exercise | 2020-12-30 4:02 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 13,800 | $1.81 | 182,989 (Direct) | View |
| 2020-12-29 Exercise | 2020-12-30 4:02 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 13,800 | $0 | 128,983 (Direct) | View |
| 2021-01-02 Tax Withholding | 2021-01-04 4:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 9,392 | $153.11 | 10,608 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 6:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 27,500 | $51.49 | 49,931 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 6:05 pm | N/A 2028-03-07 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 27,500 | $0 | 12,500 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 8,666 | $12.57 | 28,666 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,344 | $14.43 | 36,334 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A 2026-07-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 8,666 | $0 | 0 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A 2027-06-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,334 | $0 | 14,666 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:11 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $1.81 | 202,989 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:11 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $0 | 108,983 (Direct) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 615,607 | $0 | 720,481 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 158,522 | $0 | 158,522 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 158,522 | $0 | 0 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 27,716 | $0 | 27,716 (Direct) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 3,650 | $0 | 4,272 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 366,084 | $0 | 826,055 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 79,074 | $0 | 79,074 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 11,011 | $0 | 23,966 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 2,378 | $0 | 81,452 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 12,189 | $0 | 26,583 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 2,633 | $0 | 84,085 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 84,085 | $0 | 0 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 18,973 | $0 | 46,689 (Direct) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 27,861 | $0 | 62,869 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 6,018 | $0 | 6,018 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 6,018 | $0 | 0 (Indirect) | View |
| 2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 847 | $0 | 47,536 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-03 4:13 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 798 | $130.25 | 182,191 (Direct) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 244,056 | $0 | 581,999 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 52,716 | $0 | 52,716 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 7,341 | $0 | 16,625 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,585 | $0 | 54,301 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 8,126 | $0 | 18,457 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,755 | $0 | 56,056 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 56,056 | $0 | 0 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 12,648 | $0 | 60,184 (Direct) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 18,574 | $0 | 44,295 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 4,012 | $0 | 4,012 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 4,012 | $0 | 0 (Indirect) | View |
| 2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 565 | $0 | 60,749 (Direct) | View |
| 2021-03-05 Exercise | 2021-03-09 5:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 3,333 | $0 | 37,447 (Direct) | View |
| 2021-03-05 Tax Withholding | 2021-03-09 5:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 1,585 | $114.65 | 35,862 (Direct) | View |
| 2021-01-15 Exercise | 2021-03-12 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,334 | $14.43 | 26,942 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 4,583 | $0 | 40,445 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 2,141 | $124.15 | 38,304 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:41 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 23,334 | $0 | 23,334 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:43 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 2,833 | $0 | 25,264 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:43 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,353 | $124.15 | 23,911 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:43 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 25,360 | $0 | 25,360 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:43 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,583 | $0 | 15,191 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 2,141 | $124.15 | 13,050 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:47 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 33,334 | $0 | 33,334 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 11,833 | $0 | 194,024 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 5,526 | $124.15 | 188,498 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:49 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 36,000 | $0 | 36,000 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:50 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 2,833 | $0 | 3,243 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:50 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 1,352 | $124.15 | 1,891 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:50 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 25,360 | $0 | 25,360 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:50 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $44.67 | 25,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 22,000 | $51.49 | 47,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $29.87 | 57,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 20,000 | $40.87 | 77,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $14.43 | 89,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $17.66 | 101,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2027-06-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 2,666 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2027-11-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 3,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2028-03-06 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 22,000 | $0 | 38,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2029-01-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 20,000 | $0 | 25,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2030-03-10 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 43,000 (Direct) | View |
| 2021-06-01 Tax Withholding | 2021-06-03 5:34 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 779 | $115.8 | 187,719 (Direct) | View |